Denison Pharmaceuticals

Denison Pharmaceuticals is a premier contract development and manufacturing company that serves the OTC pharmaceuticals and cosmetics categories. Established in 1992, the company is a leading provider of turnkey formulation, manufacturing, and packaging solutions for the branded OTC, Rx, and Cosmetic markets. Their product dosage forms range from liquids, suspensions, creams, lotions, gels, to ointments. Located in Lincoln, Rhode Island, Denison houses a state-of-the-art manufacturing site capable of handling short, medium, and large production runs. Moreover, the company maintains two sophisticated laboratories that offer a full suite of formulation development and analytical services. In July 2013, Denison Pharmaceuticals secured a $8.00M investment in a Private Equity Round led by Midwest Mezzanine Funds. This funding injection is indicative of the confidence that investors have in the company's capabilities and potential for growth. Denison's strong positioning within the Manufacturing and Pharmaceutical industries, alongside its substantial investment, underscores its potential for expansion and heightened market influence.